Important milestone for cancer patients in Norway:
Åslaug Helland, oncologist and group leader in the department will lead a new center for clinical treatment research that receives major funding from The Research Council of Norway and the Norwegian Cancer Society:
The Research Council of Norway and the Norwegian Cancer Society have allocated 128 mill. NOK for a Centre for Clincial Treatment Research for treatment of cancer.
"This funding is an important contribution to Norwegian cancer research and will ensure that more patients will be included into clinical trials. The aim is new and better treatment alternatives for hard-to-treat cancers. We will develop next generation diagnostics and treatment for increased overall survival and quality of life for cancer patients all over Norway" says Åslaug Helland, leader of the centre.
Conferral ceremony 30. September 2021
Tine Alver and Zhi Zhao receiving their PhD ceremonial diplomas
Tine Alver and Zhi Zhao from our department, received their PhD ceremonial diplomas in the University's ceremonial hall, the Aula, on 30. September 2021.
Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, Dennis J, Lush M, Kalari KR, Goetz MP, Wang L, Cairns J, Weinshilboum R, Shepherd L, Chen BE, Häberle L, Ruebner M, Beckmann MW, He W, Larson NL, Armasu SM, Schroth W, Chowbay B, Khor CCet al.(2025) Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer NPJ Breast Cancer, 11(1), 18 DOI 10.1038/s41523-025-00733-y, PubMed 39971965
Tsuruda KM, Hektoen HH, Reis Costa D, Andreassen BK(2025) Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer Transl Lung Cancer Res, 14(1), 300-302 DOI 10.21037/tlcr-24-1002, PubMed 39958223
Alver TN, Bergholtz H, Holm MB, Dorg LT, Skrede ML, Kure EH, Verbeke CS(2025) Spatial Transcriptomics Reveals Cancer and Stromal Cell Heterogeneity Between Center and Invasive Front of Pancreatic Cancer Mod Pathol, 38(6), 100726(in press) DOI 10.1016/j.modpat.2025.100726, PubMed 39889965